CIA Surname:
Supplementary Questions
Cancer Council applications for project grants commencing 2019
Closing Date: Friday 16 March 2018
IMPORTANT NOTE TO APPLICANTS:
- Applications to the Cancer Councils comprise:
- The NHMRC RGMS application, which is to be submitted to the NHMRC in accordance with their guidelines, and
- The Supplementary Questions document, which is to be submitted by your institution's Research Admin Officer (RAO) as a PDF file to the Cancer Council Grants Secretariat ().
- The same application ID must be used on both the NHMRC application and the Supplementary Questions document.
Please name your document APP[application ID]_SuppQs_[CIA Surname]
eg APP191919_SuppQs_Smith - Cancer Councils do not offer multi-state funding. Only one Supplementary Questions document is permitted per RGMS application ID.
- Please insert application ID and CIA surname in the header
- Please use Times New Roman 12 font for all responses
- Where appropriate, place “X” next to relevant options in tables
- You mustselect“Cancer Council”as one of theorganisations from which funding is sought in Part B of the RGMS application. If you do not, NHMRC won’t release your application data to the Cancer Councils and your application will not be considered.
- Applicants mustadhere to NHMRC formatting rules for the NHMRC components of the application
- Chief Investigator A – contact details (for correspondence)
Application ID
Name
Department
Institution
Address
Suburb / State / Postcode
Telephone No / Email
- Administering Institution
Name of RAO
Department
Institution
Address
Suburb / State / Postcode
Telephone No / Email
- Lay Title of your project
Click here to enter text.
- Which Cancer Council are you applying to?
Cancer Council ACT
Cancer Council New South Wales
Cancer Council Queensland
Cancer Council South Australia (administered by SAHMRI)
Cancer Council Victoria
Cancer Council Western Australia
INVESTIGATORS
- Please list all Chief Investigators and Associate Investigators who will be named on the Cancer Council application, and the Institution they are located in.
Chief Investigator(s)
(Title, First name & Surname) / Institution
Insert additional rows as required
Associate Investigator(s)(Title, First name & Surname) / Institution
Insert additional rows as required
- Is the list and sequence of Investigators on the Cancer Council application the same as on the NHMRC application form?
Yes (You must tick ‘Yes’ if applying to Cancer Councils NSW, Qld, SA or Vic)
No Please briefly explain why the list of investigators has changed
(Cancer Councils ACT and WA applicantsonly)
Click here to enter text.
RELEVANCE TO CANCER
- Relevance to the causes, diagnosis, treatment or prevention of cancer
(½ page maximum)
Click here to enter text.
- What types of cancer does your project focus on?
All cancers / Endocrine / Lung / Pancreatic
Anal / Gynaecological / Lymphoma / Prostate
Bladder / Head and neck / Lynch Syndrome / Skin
Bone / HPV cancers / Melanoma / Sarcoma
Brain / Kidney / Mesothelioma / Stomach
Breast / Leukaemia / Myeloma / Testicular
Colorectal / Liver / Oral
Other, please name…..
- Specific State criteria (SA, VIC, WA) / Specific research area (QLD)
(1 page maximum)
Click here to enter text.
- Cancer Council Victoria applicants only: Does your project focus on low survival cancers?
Yes
No
If yes, please provide a justification as to why your project meets the criteria.
Click here to enter text.
Budget and scope of research
- Is your application also being considered for funding by the NHMRC and/or Cancer Australia?
Yes
No
For Cancer Council Victoria applicants: Please complete Question 12
For all other applicants: If ‘No’ is selected then skip Question 12
- Scope of Research
(2pagesmaximum)
12.1Provide details about the aims that will be retained and the aims that will be removed due to the reduced level of funding and/or reduced number of years.
Click here to enter text.
12.2Include a timeline which detailsthe measurable milestones you expect to achieve in each 6month interval of your funding term. To clearly demonstrate the expected progression of your project, please list every milestone you expect to achieve and when you expect to achieve it, including employment of staff, ethics approval, development of study measures, data collection (eg. expected recruitment numbers within each 6 monthly interval), data analysis, manuscript preparation etc
Click here to enter text.
12.3Include details about the changes to budget across the duration of your funding term.
Click here to enter text.
- Budget
NOTES:
- Applicants for Cancer Council Victoria funding must provide a justification for all salary requests. All CIAs requesting their own salary must also include the date that their PhD (or equivalent) was awarded.
Named Person / PSP Level / Year 1 / Year 2 / Year 3
Equipment
Maintenance
Total
Justification for salary requests (Cancer Council Victoria applicants only):
Click here to enter text.
RESEARCH SUPPORT
- Cancer Council Research Grants held by any of the Chief Investigators during the period 2014-2018
Application ID (if known) / Chief Investigators, Project Title, Year(s) grant held / Publications arising from Cancer Council funding held (PubMed ID will suffice)
COMMON SCIENTIFIC OUTLINE
The Common Scientific Outlines in Question 15 are the result of collaborative effort between the NCI in the US, the NCRI in the UK, and their partners. It is a classification system organised around seven broad areas of scientific interest in cancer research, plus subgroups. Click on the following link to view category descriptions in full
- Which categories of research best describe your application?
Biology
1.1Normal functioning
1.2Cancer initiation: Alterations in chromosomes
1.3Cancer initiation: Oncogenes and tumour suppressor genes
1.4Cancer progression and metastasis
1.5Resources and infrastructure
Aetiology
2.1Exogenous factors in the origin and cause of cancer
2.2Endogenous factors in the origin and cause of cancer
2.3Interactions of genes and/or genetic polymorphisms with exogenous and/or endogenous factors
2.4Resources and infrastructure related to aetiology
Prevention
3.1Interventions to prevent cancer: Personal behaviours that affect cancer risk
3.2Nutritional science in cancer prevention
3.3Chemoprevention
3.4Vaccines
3.5Complementary and alternative prevention approaches
3.6Resources and infrastructure related to prevention
Early Detection, Diagnosis, and Prognosis
4.1Technology development and/or marker discovery
4.2Technology and/or marker evaluation with respect to fundamental parameters of method
4.3Technology and/or marker testing in a clinical setting
4.4Resources and infrastructure related to detection, diagnosis, or prognosis
Treatment
5.1Localised therapies – Discovery and development
5.2Localised therapies – Clinical applications
5.3Systemic therapies – Discovery and development
5.4Systemic therapies – Clinical applications
5.5Combinations of localised and systemic therapies
5.6Complementary and alternative treatment approaches
5.7Resources and infrastructure related to treatment and the prevention of recurrence
Cancer Control, Survivorship, and Outcomes Research
6.1Patient care and survivorship issues
6.2Surveillance
6.3Behaviour
6.4Cost analyses and healthcare delivery
6.5Education and communication
6.6End-of-Life care
6.7Ethics and confidentiality in cancer research
6.8Complementary and alternative approaches for supportive care of patients and survivors
6.9Resources and infrastructure related to cancer control, survivorship, and outcomes research
Scientific Model Systems
7.1Development and characterisation of model systems
7.2Application of model systems
7.3Resources and infrastructure related to scientific model systems
ETHICS AND OTHER APPROVALS
- Does the research proposal submitted to the Cancer Council require/involve:
Submission to a Human Research Ethics Committee?
Submission to an institution’s Animal Ethics Committee responsible for animal research?
Organisms being genetically manipulated such that they fall under current guidelines issued by the Office of the Gene Technology Regulator?
The use of carcinogenic or highly toxic chemicals?
The use of human stem cells?
The use of animal stem cells?
A Yes/No response is required for each of the above options
ADDITIONAL INFORMATIONCancer Council ACT and Cancer Council WA applicants only
If there are Chief Investigators named on this application that are not named on the NHMRC application, please attach one page of Track Record information plus alist of publications for the last 5 years.
Click here to enter text.
1